Pharmacogenomics and pharmacogenetics of neurodegenerative diseases: towards new targets

This publication has 11 references indexed in Scilit:

• Genome-wide linkage disequilibrium mapping of late-onset Alzheimer’s disease in Finland
  Neurology, 2001
• Epidemiological methods for studying genes and environmental factors in complex diseases
  The Lancet, 2001
• SNPing Away at Complex Diseases: Analysis of Single-Nucleotide Polymorphisms around APOE in Alzheimer Disease
  American Journal of Human Genetics, 2000
• Contribution of trends in survival and coronar y-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations
  The Lancet, 1999
• Mortality by cause for eight regions of the world: Global Burden of Disease Study
  Published by Elsevier ,1997
• APOE genotyping and response to drug treatment in Alzheimer's disease
  The Lancet, 1997
• Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease.
  Proceedings of the National Academy of Sciences, 1995
• Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
  Proceedings of the National Academy of Sciences, 1993
• Apolipoprotein E polymorphism and atherosclerosis.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
• Aging, Natural Death, and the Compression of Morbidity
  New England Journal of Medicine, 1980